Ixia (XXIA)

Add to Watchlists
Create an Alert
19.65 +0.00  +0.00% NASDAQ Apr 18, 20:00 Delayed 2m USD

Ixia Research and Development Expense (Quarterly):

25.02M for Dec. 31, 2016
View 4,000+ financial data types
View Full Chart

Ixia Research and Development Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Ixia Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2016 25.02M
Sept. 30, 2016 25.58M
June 30, 2016 24.47M
March 31, 2016 27.46M
Dec. 31, 2015 29.52M
Sept. 30, 2015 28.54M
June 30, 2015 27.76M
March 31, 2015 27.63M
Dec. 31, 2014 27.48M
Sept. 30, 2014 27.61M
June 30, 2014 30.03M
March 31, 2014 30.04M
Dec. 31, 2013 29.32M
Sept. 30, 2013 29.40M
June 30, 2013 29.07M
March 31, 2013 29.71M
Dec. 31, 2012 29.01M
Sept. 30, 2012 25.76M
June 30, 2012 22.55M
March 31, 2012 20.85M
Dec. 31, 2011 19.10M
Sept. 30, 2011 18.93M
June 30, 2011 18.54M
March 31, 2011 18.52M
Dec. 31, 2010 18.16M
Sept. 30, 2010 17.80M
June 30, 2010 17.88M
March 31, 2010 18.64M
Dec. 31, 2009 16.98M
Sept. 30, 2009 13.69M
June 30, 2009 11.44M
March 31, 2009 11.87M
Dec. 31, 2008 12.17M
Sept. 30, 2008 12.48M
June 30, 2008 12.53M
March 31, 2008 11.99M
Dec. 31, 2007 12.03M
Sept. 30, 2007 12.77M
June 30, 2007 10.94M
March 31, 2007 11.67M
Dec. 31, 2006 10.73M
Sept. 30, 2006 11.10M
June 30, 2006 11.06M
March 31, 2006 10.56M
Dec. 31, 2005 8.89M
Sept. 30, 2005 7.994M
June 30, 2005 7.974M
March 31, 2005 7.546M
Dec. 31, 2004 7.234M
Sept. 30, 2004 6.544M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More


XXIA Research and Development Expense (Quarterly) Benchmarks

Gigamon 17.17M
Acxiom 20.95M
NCR 67.00M

XXIA Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 22.55M Jun 2012
Maximum 30.04M Mar 2014
Average 27.68M

XXIA Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("XXIA", "r_and_d_expense")
  • Last 5 data points: =YCS("XXIA", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.